NYSE:WST West Pharmaceutical Services (WST) Stock Price, News & Analysis $332.81 +13.06 (+4.08%) As of 01:54 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About West Pharmaceutical Services Stock (NYSE:WST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get WST alerts:Sign Up Key Stats Today's Range$326.69▼$334.6050-Day Range$243.53▼$326.1252-Week Range$206.80▼$334.60Volume305,651 shsAverage Volume928,017 shsMarket Capitalization$23.51 billionP/E Ratio44.55Dividend Yield0.26%Price Target$340.09Consensus RatingBuy Company Overview West Pharmaceutical Services, Inc. is a global developer and manufacturer of components, systems and services that enable the containment and delivery of injectable drugs. The company focuses on high-quality packaging and delivery solutions for the pharmaceutical and biotech industries, producing primary drug packaging components and specialized drug delivery devices used for vaccines, biologics and other injectable therapies. West is known for its elastomeric closures, seals and polymer components that maintain sterility and compatibility with sensitive drug formulations. In addition to component manufacturing, West provides engineered delivery systems and support services across the product lifecycle. Its offerings include stoppers and seals, custom-molded polymer parts, prefillable syringe systems and a range of delivery device technologies for self-administration. The company also offers development assistance, analytical testing, regulatory support and contract manufacturing, helping customers take complex parenteral products from design through commercial production while meeting stringent quality and compliance requirements. West serves a global customer base that includes large pharmaceutical companies, emerging biotech firms and contract development and manufacturing organizations. The company operates manufacturing, research and development, and quality centers across multiple regions to support international supply chains and regulatory markets in North America, Europe, Asia-Pacific and Latin America. With an emphasis on innovation and quality control, West positions itself as a partner for customers seeking reliable containment and delivery solutions for advanced injectable therapies.AI Generated. May Contain Errors. Read More West Pharmaceutical Services Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks79th Percentile Overall ScoreWST MarketRank™: West Pharmaceutical Services scored higher than 79% of companies evaluated by MarketBeat, and ranked 99th out of 865 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.7 / 5Analyst RatingBuy Consensus RatingWest Pharmaceutical Services has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, 10 buy ratings, 2 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for West Pharmaceutical Services is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageWest Pharmaceutical Services has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about West Pharmaceutical Services' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth10.47% Earnings GrowthEarnings for West Pharmaceutical Services are expected to grow by 10.47% in the coming year, from $8.60 to $9.50 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of West Pharmaceutical Services is 44.33, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.81.Price to Earnings Ratio vs. SectorThe P/E ratio of West Pharmaceutical Services is 44.33, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.94.Price to Earnings Growth RatioWest Pharmaceutical Services has a PEG Ratio of 2.63. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioWest Pharmaceutical Services has a P/B Ratio of 7.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about West Pharmaceutical Services' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.25% of the float of West Pharmaceutical Services has been sold short.Short Interest Ratio / Days to CoverWest Pharmaceutical Services has a short interest ratio ("days to cover") of 2.63, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in West Pharmaceutical Services has recently decreased by 5.92%, indicating that investor sentiment is improving significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldWest Pharmaceutical Services has a dividend yield of 0.28%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthWest Pharmaceutical Services does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of West Pharmaceutical Services is 11.76%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 9.26% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.Read more about West Pharmaceutical Services' dividend. News and Social Media3.8 / 5News Sentiment1.13 News SentimentWest Pharmaceutical Services has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for West Pharmaceutical Services this week, compared to 6 articles on an average week.Search InterestOnly 3 people have searched for WST on MarketBeat in the last 30 days. This is a decrease of -79% compared to the previous 30 days.MarketBeat Follows2 people have added West Pharmaceutical Services to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, West Pharmaceutical Services insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,129,149.00 in company stock.Percentage Held by Insiders0.60% of the stock of West Pharmaceutical Services is held by insiders.Percentage Held by Institutions93.90% of the stock of West Pharmaceutical Services is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about West Pharmaceutical Services' insider trading history. Receive WST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WST Stock News HeadlinesWolfe Research Says West Pharmaceutical Services (WST) is Positioned to Benefit from Injectable Drug GrowthJune 8 at 12:50 AM | insidermonkey.comHow The West Pharmaceutical Services (WST) Story Is Evolving With Guidance Buybacks And New LeadershipJune 7 at 6:04 PM | finance.yahoo.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.June 9 at 1:00 AM | InvestorPlace (Ad)Wolfe Research Weighs on West Pharmaceutical Services Inc (WST) StockJune 7 at 2:51 PM | insidermonkey.comWolfe Research Weighs on West Pharmaceutical Services Inc (WST) StockJune 7 at 2:10 PM | finance.yahoo.comWest Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conference - SlideshowJune 4, 2026 | seekingalpha.comWest Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks TranscriptJune 2, 2026 | seekingalpha.comWest Pharmaceutical Names Michel Lagarde Next CEOJune 1, 2026 | tipranks.comSee More Headlines WST Stock Analysis - Frequently Asked Questions How have WST shares performed this year? West Pharmaceutical Services' stock was trading at $275.53 on January 1st, 2026. Since then, WST shares have increased by 20.3% and is now trading at $331.5470. How were West Pharmaceutical Services' earnings last quarter? West Pharmaceutical Services, Inc. (NYSE:WST) announced its quarterly earnings data on Thursday, April, 23rd. The medical instruments supplier reported $2.13 earnings per share for the quarter, topping the consensus estimate of $1.68 by $0.45. The business's revenue for the quarter was up 21.0% on a year-over-year basis. Read the conference call transcript. How will West Pharmaceutical Services' stock buyback program work? West Pharmaceutical Services' Board of Directors approved a stock buyback plan on Tuesday, February 17th 2026, which permits the company to buy back $1,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 5.6% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's leadership believes its stock is undervalued. Does West Pharmaceutical Services have any subsidiaries? West Pharmaceutical Services subsidiaries include Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., The Tech Group Inc., Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), TGPR Holdings Limited, WD SG Pte. Ltd., and more. Who are West Pharmaceutical Services' major shareholders? Top institutional investors of West Pharmaceutical Services include Bank of New York Mellon Corp (3.49%), Amundi (0.91%), Epoch Investment Partners Inc. (0.77%) and Sei Investments Co. (0.75%). Insiders that own company stock include Eric Mark Green, Thomas W Hofmann, Quintin J Lai, Annette F Favorite, Bernard Birkett, Cindy Reiss-Clark, Silji Abraham, Chad Winters and Charles Witherspoon. View institutional ownership trends. How do I buy shares of West Pharmaceutical Services? Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of West Pharmaceutical Services own? Based on aggregate information from My MarketBeat watchlists, some other companies that West Pharmaceutical Services investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Home Depot (HD), Chevron (CVX) and Netflix (NFLX). Company Calendar Last Earnings4/23/2026Record date for 5/6 Dividend4/29/2026Ex-Dividend for 5/6 Dividend4/29/2026Dividend Payable5/06/2026Today6/09/2026Next Earnings (Estimated)7/23/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 WST's financial health is in the Green zone, according to TradeSmith. WST has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED/DENTAL - SUPP Sub-IndustryHealth Care Supplies Current SymbolNYSE:WST CIK105770 Webwww.westpharma.com Phone(610) 594-2900Fax800-345-9800Employees10,800Year Founded1923Price Target and Rating Average Price Target for West Pharmaceutical Services$340.09 High Price Target$400.00 Low Price Target$295.00 Potential Upside/Downside+2.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)$7.48 Trailing P/E Ratio44.49 Forward P/E Ratio38.70 P/E Growth2.63Net Income$493.70 million Net Margins16.85% Pretax Margin20.82% Return on Equity19.03% Return on Assets14.06% Debt Debt-to-Equity Ratio0.07 Current Ratio2.71 Quick Ratio2.04 Sales & Book Value Annual Sales$3.07 billion Price / Sales7.65 Cash Flow$10.30 per share Price / Cash Flow32.30 Book Value$44.10 per share Price / Book7.55Miscellaneous Outstanding Shares70,650,000Free Float70,224,000Market Cap$23.51 billion OptionableOptionable Beta1.18 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NYSE:WST) was last updated on 6/9/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding West Pharmaceutical Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share West Pharmaceutical Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
